Fluidigm Corporation (FLDM) and Press Ganey Holdings (PGND) Financial Survey
Press Ganey Holdings (NYSE: PGND) and Fluidigm Corporation (NASDAQ:FLDM) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, risk, dividends, earnings and institutional ownership.
This table compares Press Ganey Holdings and Fluidigm Corporation’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Press Ganey Holdings||8.69%||5.46%||3.34%|
Earnings & Valuation
This table compares Press Ganey Holdings and Fluidigm Corporation’s top-line revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Press Ganey Holdings||N/A||N/A||N/A||$0.51||79.41|
|Fluidigm Corporation||$96.72 million||1.58||-$62.62 million||($2.46)||-2.11|
Press Ganey Holdings has higher revenue, but lower earnings than Fluidigm Corporation. Fluidigm Corporation is trading at a lower price-to-earnings ratio than Press Ganey Holdings, indicating that it is currently the more affordable of the two stocks.
Volatility & Risk
Press Ganey Holdings has a beta of 0.99, indicating that its stock price is 1% less volatile than the S&P 500. Comparatively, Fluidigm Corporation has a beta of 3.37, indicating that its stock price is 237% more volatile than the S&P 500.
Institutional and Insider Ownership
91.9% of Press Ganey Holdings shares are held by institutional investors. Comparatively, 88.9% of Fluidigm Corporation shares are held by institutional investors. 5.1% of Press Ganey Holdings shares are held by company insiders. Comparatively, 4.7% of Fluidigm Corporation shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
This is a summary of current ratings and target prices for Press Ganey Holdings and Fluidigm Corporation, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Press Ganey Holdings||0||0||0||0||N/A|
Fluidigm Corporation has a consensus target price of $9.00, suggesting a potential upside of 73.41%. Given Fluidigm Corporation’s higher possible upside, analysts plainly believe Fluidigm Corporation is more favorable than Press Ganey Holdings.
Press Ganey Holdings beats Fluidigm Corporation on 6 of the 10 factors compared between the two stocks.
About Press Ganey Holdings
Press Ganey Holdings, Inc. is a provider of patient experience and caregiver measurement, performance analytics and strategic advisory solutions for healthcare organizations. The Company provides its clients with a digital platform that captures the perspectives of patients, physicians, nurses and other healthcare employees and enables its clients to benchmark, analyze and manage the patient and caregiver experience. Its solutions include Patient Experience Solutions, which include Patient experience measurement, insights and advisory services; Caregiver Engagement Solutions, which include Physician, nurse and employee engagement measurement, insights and advisory services; Clinical and Quality Solutions, which include nursing quality indicators, patient reported outcome measures, core measures and eMeasures, and Consulting Solutions, which include patient safety and care reliability, patient experience improvement, process flow, advanced analytics and insights and cultural alignment.
About Fluidigm Corporation
Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment. Its products include preparatory instruments, preparatory analytical instruments, analytical instruments, integrated fluidic circuits (IFCs), and assays and reagents. Its preparatory instruments include C1 Single-Cell Auto Prep System, Access Array System, Juno System and IFCs, and Callisto System and IFC. Its analytical instruments include Biomark HD System, EP1 System and Helios/CyTOF 2 System. Its assays and reagents include Delta Gene and SNP Type Assays, and Access Array Target-Specific Primers and Targeted Sequencing Prep Primers.
Receive News & Ratings for Press Ganey Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Press Ganey Holdings Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.